Sleep stage transitions in healthy humans altered by central monoaminergic antagonist

Methods of Information in Medicine

Volumn 49, Issue 5, 2010, Pages 458-461

  Kishi, A ^a,b   Yasuda, H ^c   Matsumoto, T ^d   Inami, Y ^e   Horiguchi, J ^c   Struzik, Z R ^a   Yamamoto, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d Seiwakai Nishikawa Hospital   (Japan)

^e N   (Japan)

Author keywords

Dopamine; REM onset interval; Risperidone; Serotonin; Sleep stage transitions

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; RISPERIDONE;

ADULT; ARTICLE; DRUG EFFECT; HUMAN; MALE; ORAL DRUG ADMINISTRATION; REFERENCE VALUE; REM SLEEP; SLEEP STAGE;

ADMINISTRATION, ORAL; ADULT; DOPAMINE ANTAGONISTS; HUMANS; MALE; REFERENCE VALUES; RISPERIDONE; SLEEP STAGES; SLEEP, REM; YOUNG ADULT;

EID: 79952277302     PISSN: 00261270     EISSN: None     Source Type: Journal    
DOI: 10.3414/ME09-02-0032     Document Type: Article

References (22)

1. Hobson JA, Lydic R, Baghdoyan HA. Evolving concepts of sleep cycle generation: from brain centers to neuronal populations. Behav Brain Sci 1986; 9: 371-448.
2. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wake -fulness. Trends Neurosci 2001; 24: 726-731.
3. Pace-Schott EF, Hobson JA. The neurobiology of sleep: genetics, cellular physiology and sub -cortical networks. Nat Rev Neurosci 2002; 3: 591-605.
4. Pace-Schott EF, Hobson JA. Basic mechanisms of sleep: new evidence on the neuroanatomy and neuromodulation of the NREM-REM cycle. In: Kenneth LD, Dennis C, Joseph TC, Charles N, editors. Neuropsychopharmacology: the fifth generation of progress. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. pp 1859-1877.
5. Jones BE. Paradoxical REM sleep promoting and permitting neuronal networks. Arch Ital Biol 2004; 142: 379-396.
6. Luppi PH, et al. Brainstem structures responsible for paradoxical sleep onset and maintenance. Arch Ital Biol 2004; 142: 379-396.
7. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep states of human subjects. Washington, DC: US Government Printing Office; 1968.
8. Lo CC, et al. Dynamics of sleep-wake transitions during sleep. Europhys Lett 2002; 57: 625-631.
9. Lo CC, et al. Common scale-invariant patterns of sleep-wake transitions across mammalian species. Proc Natl Acad Sci USA 2004; 101: 17545-17548.
10. Comte JC, Ravassard P, Salin PA. Sleep dynamics: a self-organized critical system. Phys Rev E Stat Nonlin Soft Matter Phys 2006; 73: 056127.
11. Kishi A, et al. Dynamics of sleep stage transitions in healthy humans and patients with chronic fatigue syndrome. Am J Physiol Regul Integr Comp Physiol 2008; 294: 1980-1987.
12. Carskadon MA, Dement WC. Normal human sleep overview. In: Kryger MH, Roth T, Dement WC (eds). Principles and practice of sleep medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005. pp 13-23.
13. Phillips AJK, Robinson PA. A quantitative model of sleep-wake dynamics based on the physiology of the brainstem ascending arousal system. J Biol Rhythms 2007; 22: 167-179.
14. Matsumoto M, et al. Effect of risperidone on polysomnography in healthy subjects. Sleep Biol Rhythms 2007; 5: 146-148.
15. McCarley RW, Hobson JA. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 1975; 189: 58-60.
16. Sitaram N, Moore AM, Gillin JC. Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 1978; 274: 490-492.
17. Benington JH, Heller HC. Monoaminergic and cholinergic modulation of REM-sleep timing in rats. Brain Res 1995; 681: 141-146.
18. Feinberg I. Changes in sleep cycle patterns with age. J Psychiat Res 1974; 10: 283-306.
19. Moses J, et al. Rapid eye movement cycle is a sleepdependent rhythm. Nature 1977; 265: 360-361.
20. Sharpley AI, et al. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry 2003; 64: 192-196.
21. Giménes S, et al. Effects of olanzapine, risperidone and haloperidol on sleep after single oral morning dose in healthy volunteers. Psychopharmacology 2007; 190: 507-516.
22. Yamashita H, et al. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiat Res 2002; 109: 137-142.